Richard Scheller, PhD
Chief Scientific Officer and Head of Therapeutic Development, 23andMe
Richard is chief scientific officer and head of therapeutic development at 23andMe. He received his BS from UW-Madison, his doctorate from Caltech, and completed postdoctoral fellowships at Caltech and Columbia. Stanford faculty member from 1982 to 2001, he is an adjunct professor at UCSF, and a trustee of Caltech. Hired by Genentech to lead research in 2001, Scheller departed in 2014 as EVP of R&D and member of the Roche executive committee. His research elucidating molecular mechanisms governing neurotransmitter release earned him the 2013 Albert Lasker Basic Medical Research Award, the 2010 Kavli Prize in Neuroscience, and the 1997 NAS Award in Molecular Biology. He is a fellow of the American Academy, and a member of the NAS and the NAM.